Clinical Trial Update: Changes to Vulva, Vestibule, Urethral Meatus and Vagina 20 Weeks Post Daily Prasterone in Women With Dyspareunia [Phase 4]

View source ↗

Summary

Clinical trial update from a Phase 4 study assessing daily prasterone effects on vulvar and vaginal tissues in women with dyspareunia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspareunia

Drugs mentioned

• Prasterone (dehydroepiandrosterone (DHEA))

Snippet

Sponsor: San Diego Sexual Medicine | Conditions: Dyspareunia | Phase 4 | Status: COMPLETED